Related Experiment Video
Updated: Jun 11, 2025
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response
Selma Rivas-Fuentes1, Alfonso Salgado-Aguayo2, Teresa Santos-Mendoza1
1Laboratory of Transcriptomics and Molecular Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
Insights
Respiratory syncytial virus (RSV) uses the fractalkine receptor (CX3CR1) to infect hosts. Understanding this interaction is key to developing new RSV vaccines and treatments.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Respiratory syncytial virus (RSV) causes significant respiratory illness, particularly in infants and older adults.
- RSV is a leading cause of pediatric pneumonia deaths, yet effective vaccines are limited.
- Understanding the molecular mechanisms of RSV-host interaction is crucial for improved disease management.
Purpose of the Study:
- To investigate the role of the fractalkine (CX3CL1) receptor (CX3CR1) as a co-receptor for RSV.
- To elucidate how the RSV G protein interacts with the CX3CR1-CX3CL1 axis.
- To explore the implications of this interaction for host immune response and therapeutic development.
Main Methods:
- Analysis of the conserved CX3C motif in the RSV G protein and its binding to CX3CR1.
- Investigation of the CX3CL1-CX3CR1 axis in immune cell activation and lung infiltration during RSV infection.
- Evaluation of how RSV G protein binding alters CX3CR1-CX3CL1 axis function.
Main Results:
- The RSV G protein binds to the CX3CR1 receptor through a conserved CX3C motif.
- The CX3CL1-CX3CR1 axis is implicated in immune cell recruitment to the lungs during RSV infection.
- RSV G protein binding disrupts normal CX3CR1-CX3CL1 axis function, modifying the host immune response.
Conclusions:
- The interaction between the RSV G protein and CX3CR1 is a critical factor in RSV pathogenesis.
- Targeting the CX3CL1-CX3CR1 axis presents a potential strategy for novel RSV therapies.
- Further research into this molecular interaction is necessary for developing effective RSV vaccines and treatments.
Abstract:
Respiratory syncytial virus (RSV) is a common respiratory pathogen that causes respiratory illnesses, ranging from mild symptoms to severe lower respiratory tract infections in infants and older adults. This virus is responsible for one-third of pneumonia deaths in the pediatric population; however, there are currently only a few effective vaccines. A better understanding of the RSV-host relationship at the molecular level may lead to a more effective management of RSV-related symptoms. The fractalkine (CX3CL1) receptor (CX3CR1) is a co-receptor for RSV expressed by airway epithelial cells and diverse immune cells. RSV G protein binds to the CX3CR1 receptor via a highly conserved amino acid motif (CX3C motif), which is also present in CX3CL1. The CX3CL1-CX3CR1 axis is involved in the activation and infiltration of immune cells into the infected lung. The presence of the RSV G protein alters the natural functions of the CX3CR1-CX3CL1 axis and modifies the host's immune response, an aspects that need to be considered in the development of an efficient vaccine and specific pharmacological treatment.
